Robert O. Friedel

1.8k total citations
69 papers, 1.4k citations indexed

About

Robert O. Friedel is a scholar working on Psychiatry and Mental health, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Robert O. Friedel has authored 69 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Psychiatry and Mental health, 15 papers in Cellular and Molecular Neuroscience and 14 papers in Molecular Biology. Recurrent topics in Robert O. Friedel's work include Treatment of Major Depression (11 papers), Neuroscience and Neuropharmacology Research (10 papers) and Schizophrenia research and treatment (9 papers). Robert O. Friedel is often cited by papers focused on Treatment of Major Depression (11 papers), Neuroscience and Neuropharmacology Research (10 papers) and Schizophrenia research and treatment (9 papers). Robert O. Friedel collaborates with scholars based in United States, Japan and Czechia. Robert O. Friedel's co-authors include Jack Durell, S. M. Schanberg, Nicholas G. Ward, Robert M. Hamer, John T. Garland, N. Narasimhachari, Robert J. Bielski, S. Charles Schulz, P. R. S. Kishore and M. Köller and has published in prestigious journals such as Science, American Journal of Psychiatry and Analytical Biochemistry.

In The Last Decade

Robert O. Friedel

67 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert O. Friedel United States 21 446 402 343 241 239 69 1.4k
Dorothy A. Kinscherf United States 21 586 1.3× 384 1.0× 484 1.4× 106 0.4× 83 0.3× 24 1.5k
A.I.M. Glen United Kingdom 20 689 1.5× 539 1.3× 286 0.8× 485 2.0× 294 1.2× 45 2.2k
L. Bjerkenstedt Sweden 23 713 1.6× 355 0.9× 461 1.3× 199 0.8× 109 0.5× 50 1.4k
Tommy Lewander Sweden 30 726 1.6× 638 1.6× 1.1k 3.3× 287 1.2× 215 0.9× 100 2.6k
T. Meert Belgium 20 381 0.9× 445 1.1× 723 2.1× 183 0.8× 144 0.6× 44 1.7k
T B Cooper United States 21 708 1.6× 432 1.1× 595 1.7× 202 0.8× 201 0.8× 35 1.8k
David L. Garver United States 28 988 2.2× 430 1.1× 591 1.7× 259 1.1× 148 0.6× 82 2.3k
David J. Brunswick United States 27 424 1.0× 607 1.5× 857 2.5× 418 1.7× 98 0.4× 70 1.9k
R J Baldessarini United States 28 566 1.3× 746 1.9× 946 2.8× 229 1.0× 99 0.4× 62 2.1k
Frits‐Axel Wiesel Sweden 27 1.1k 2.6× 551 1.4× 1.1k 3.2× 312 1.3× 229 1.0× 65 2.5k

Countries citing papers authored by Robert O. Friedel

Since Specialization
Citations

This map shows the geographic impact of Robert O. Friedel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert O. Friedel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert O. Friedel more than expected).

Fields of papers citing papers by Robert O. Friedel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert O. Friedel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert O. Friedel. The network helps show where Robert O. Friedel may publish in the future.

Co-authorship network of co-authors of Robert O. Friedel

This figure shows the co-authorship network connecting the top 25 collaborators of Robert O. Friedel. A scholar is included among the top collaborators of Robert O. Friedel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert O. Friedel. Robert O. Friedel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Friedel, Robert O., Christian Schmahl, & Marijn A. Distel. (2018). The Neurobiological Basis of Borderline Personality Disorder. Oxford University Press eBooks.
2.
Friedel, Robert O.. (2006). Early sea changes in borderline personality disorder. Current Psychiatry Reports. 8(1). 1–4. 4 indexed citations
3.
Friedel, Robert O.. (2004). Dopamine Dysfunction in Borderline Personality Disorder: A Hypothesis. Neuropsychopharmacology. 29(6). 1029–1039. 105 indexed citations
4.
Friedel, Robert O.. (1999). The future of psychiatry is here. Current Psychiatry Reports. 1(2). 99–100. 1 indexed citations
5.
Resnick, Robert, Solomon C. Goldberg, S. Charles Schulz, et al.. (1988). Borderline personality disorder: Replication of MMPI profiles. Journal of Clinical Psychology. 44(3). 354–360. 5 indexed citations
6.
Schulz, S. Charles, Patricia M. Schulz, Robert M. Hamer, et al.. (1985). Amphetamine response in borderline patients. Psychiatry Research. 15(2). 97–108. 21 indexed citations
7.
Goldberg, Sanford C., et al.. (1983). Therapeutic practice with tricyclic antidepressants among expert and general practice psychiatrists. Neuropharmacology. 22(4). 543–548. 3 indexed citations
8.
Veith, Richard C., et al.. (1983). Urinary MHPG excretion and treatment with desipramine or amitriptyline: prediction of response, effect of treatment, and methodological hazards.. PubMed. 3(1). 18–27. 24 indexed citations
9.
Shand, David G., Michael R. Hall, Stephen H. Buck, et al.. (1982). Opening Remarks by Prof. M. Bergener, Köln. Gerontology. 28(1). 1–4. 3 indexed citations
10.
Saady, Joseph J., et al.. (1981). A comparison of plasma and serum levels of two tricyclic antidepressants: Imipramine and desipramine. Psychopharmacology. 75(2). 173–174. 3 indexed citations
12.
Ward, Nicholas G., et al.. (1979). The effectiveness of tricyclic antidepressants in the treatment of coexisting pain and depression. Pain. 7(3). 331–341. 133 indexed citations
13.
Friedel, Robert O., et al.. (1979). Desipramine plasma levels and clinical response in depressed outpatients.. PubMed. 3(2). 81–7. 33 indexed citations
14.
Friedel, Robert O., et al.. (1979). Relationship of plasma levels of chlordiazepoxide and metabolites to clinical response. American Journal of Psychiatry. 136(1). 18–23. 23 indexed citations
15.
Friedel, Robert O., Robert Nathan Slotnick, & Paul A. Bombardt. (1977). Effects of γ-aminobutyric acid on 33Pi incorporation into rat brain phospholipids. Life Sciences. 20(2). 235–241. 1 indexed citations
16.
Friedel, Robert O.. (1976). Lithium and Depression. American Journal of Psychiatry. 133(8). 976–976. 4 indexed citations
17.
Friedel, Robert O., et al.. (1974). Effects of dopamine and norepinephrine on phospholipid metabolism of rat brain in vivo: regional differences. Journal of Neurochemistry. 22(5). 873–875. 20 indexed citations
18.
Friedel, Robert O., J. R. Johnson, & S. M. Schanberg. (1973). EFFECTS OF SYMPATHOMIMETIC DRUGS ON INCORPORATION IN VIVO OF INTRACISTERNALLY INJECTED 33Pi INTO PHOSPHOLIPIDS OF RAT BRAIN. Journal of Pharmacology and Experimental Therapeutics. 184(3). 583–589. 27 indexed citations
19.
Bressler, B & Robert O. Friedel. (1971). A Comparison between Chlorpromazine and Thiothixene in a Veterans Administration Hospital Population. Psychosomatics. 12(4). 275–277. 7 indexed citations
20.
Friedel, Robert O., et al.. (1957). Conference on high power electrical impulse techniques : January 28, 29, 1957. European Journal of Cell Biology. 33(1). 66–74. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026